142 related articles for article (PubMed ID: 15201964)
1. Sensitivity of scirrhous gastric cancer to 5-fluorouracil and the role of cancer cell-stromal fibroblast interaction.
Nakajima K; Okita Y; Matsuda S
Oncol Rep; 2004 Jul; 12(1):85-90. PubMed ID: 15201964
[TBL] [Abstract][Full Text] [Related]
2. An in-vitro model of scirrhous carcinoma of the stomach using stomach fibroblasts derived from gastric cancer patients.
Kikuchi S; Sato T; Arai Y; Tsutsumi O; Hiki Y; Kakita A
Hepatogastroenterology; 2000; 47(35):1256-9. PubMed ID: 11100326
[TBL] [Abstract][Full Text] [Related]
3. Tranilast (N-3,4-dimethoxycinamoyl anthranilic acid): a novel inhibitor of invasion-stimulating interaction between gastric cancer cells and orthotopic fibroblasts.
Yashiro M; Murahashi K; Matsuoka T; Nakazawa K; Tanaka H; Osaka H; Koyama T; Ohira M; Chung KH
Anticancer Res; 2003; 23(5A):3899-904. PubMed ID: 14666694
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical study of collagen synthesis in an in-vitro model of scirrhous carcinoma of the stomach.
Kurita A; Kikuchi S; Kakita A
Hepatogastroenterology; 2002; 49(47):1235-8. PubMed ID: 12239912
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical distribution of heat shock protein 47 (HSP47) in scirrhous carcinoma of the stomach.
Hirai K; Kikuchi S; Kurita A; Ohashi S; Adachi E; Matsuoka Y; Nagata K; Watanabe M
Anticancer Res; 2006; 26(1A):71-8. PubMed ID: 16475681
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of 5-fluorouracil on glucose transport and expressions of glucose transporter proteins in gastric cancer cells.
Won HJ; Ha TK; Kwon SJ; Cho HY; Hur SJ; Baik HH; Suh SI; Ha E; Kim YH
Anticancer Drugs; 2010 Mar; 21(3):270-6. PubMed ID: 20023572
[TBL] [Abstract][Full Text] [Related]
7. [Effect of 5-FU on the utilization of purine and pyrimidine by human gastric cancer cells (KATO III)].
Usami M; Wang J; Yasuda I; Saitoh Y; Yumisashi T; Abe K
Gan To Kagaku Ryoho; 1995 May; 22(6):747-51. PubMed ID: 7755382
[TBL] [Abstract][Full Text] [Related]
8. Tranilast (N-(3,4-dimethoxycinnamoyl) anthranilic acid) down-regulates the growth of scirrhous gastric cancer.
Yashiro M; Chung YS; Sowa M
Anticancer Res; 1997; 17(2A):895-900. PubMed ID: 9137424
[TBL] [Abstract][Full Text] [Related]
9. Keratinocyte growth factor produced by gastric fibroblasts specifically stimulates proliferation of cancer cells from scirrhous gastric carcinoma.
Nakazawa K; Yashiro M; Hirakawa K
Cancer Res; 2003 Dec; 63(24):8848-52. PubMed ID: 14695201
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effect of a selective cyclooxygenase inhibitor on the invasion-stimulating activity of orthotopic fibroblasts for scirrhous gastric cancer cells.
Tendo M; Yashiro M; Nakazawa K; Yamada N; Hirakawa K
Cancer Sci; 2005 Jul; 96(7):451-5. PubMed ID: 16053517
[TBL] [Abstract][Full Text] [Related]
11. [Pathogenesis and progression of scirrhous carcinoma].
Naito Y; Kino I
Gan To Kagaku Ryoho; 1994 Oct; 21(14):2364-70. PubMed ID: 7944478
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of the orotate phosphoribosyl-transferase gene enhances the effect of 5-fluorouracil on gastric cancer cell lines.
Taomoto J; Yoshida K; Wada Y; Tanabe K; Konishi K; Tahara H; Fukushima M
Oncology; 2006; 70(6):458-64. PubMed ID: 17237621
[TBL] [Abstract][Full Text] [Related]
13. [Antitumor effects of specific cyclooxygenase inhibitors combined with chemotherapeutic agents on gastric cancer cells in vitro].
Zhu FS; Chen XM; Wang YJ; Zhang X; Feng JX
Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):186-8. PubMed ID: 17649633
[TBL] [Abstract][Full Text] [Related]
14. Identification of novel genes associated with the response to 5-FU treatment in gastric cancer cell lines using a cDNA microarray.
Park JS; Young Yoon S; Kim JM; Yeom YI; Kim YS; Kim NS
Cancer Lett; 2004 Oct; 214(1):19-33. PubMed ID: 15331170
[TBL] [Abstract][Full Text] [Related]
15. Fibrosis in the peritoneum induced by scirrhous gastric cancer cells may act as "soil" for peritoneal dissemination.
Yashiro M; Chung YS; Nishimura S; Inoue T; Sowa M
Cancer; 1996 Apr; 77(8 Suppl):1668-75. PubMed ID: 8608560
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of mitochondrial F1F0-ATP synthase in human colon cancer cells with induced 5-fluorouracil resistance.
Shin YK; Yoo BC; Chang HJ; Jeon E; Hong SH; Jung MS; Lim SJ; Park JG
Cancer Res; 2005 Apr; 65(8):3162-70. PubMed ID: 15833846
[TBL] [Abstract][Full Text] [Related]
17. The evaluation of gastric cancer sensitivity to 5-FU/CDDP in terms of induction of apoptosis: time- and p53 expression-dependency of anti-cancer drugs.
Matsuhashi N; Saio M; Matsuo A; Sugiyama Y; Saji S
Oncol Rep; 2005 Sep; 14(3):609-15. PubMed ID: 16077963
[TBL] [Abstract][Full Text] [Related]
18. Synergistic antitumor effects of FGFR2 inhibitor with 5-fluorouracil on scirrhous gastric carcinoma.
Yashiro M; Shinto O; Nakamura K; Tendo M; Matsuoka T; Matsuzaki T; Kaizaki R; Miwa A; Hirakawa K
Int J Cancer; 2010 Feb; 126(4):1004-16. PubMed ID: 19621385
[TBL] [Abstract][Full Text] [Related]
19. A microplate assay for selective measurement of growth of epithelial tumor cells in direct coculture with stromal cells.
Kawada M; Yoshimoto Y; Minamiguchi K; Kumagai H; Someno T; Masuda T; Ishizuka M; Ikeda D
Anticancer Res; 2004; 24(3a):1561-8. PubMed ID: 15274323
[TBL] [Abstract][Full Text] [Related]
20. Tranilast inhibits hormone refractory prostate cancer cell proliferation and suppresses transforming growth factor beta1-associated osteoblastic changes.
Izumi K; Mizokami A; Li YQ; Narimoto K; Sugimoto K; Kadono Y; Kitagawa Y; Konaka H; Koh E; Keller ET; Namiki M
Prostate; 2009 Aug; 69(11):1222-34. PubMed ID: 19434660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]